This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Latteno Food Issues Update Report On Current Operations

SANTA ANA, Calif., May 1, 2013 /PRNewswire/ -- Latteno Food Corp. (OTCPink: LATF) issues an operational update on the implementation of its recently announced enhanced business plan and new strategic direction that included a corporate-wide re-branding and the commencement of its pioneering expansion into the exploding new marketplace of medical marijuana and cannabis edibles; as well as the lucrative fresh seafood importation business.

The Company has moved quickly with the implementation of its new initiatives through strategic acquisitions, innovative development projects and tactical licensing arrangements and has substantially grown and strengthened its revenue projections and asset valuation.

Highlights:

Jan. 10, 2013  - New Board and Officers announced a New Business Plan that called for acquisitions and growth in the Medical Marijuana Industry which is currently estimated to be a $1.7 - $2.0 Billion and according to some estimates could be as large $46.2 billion if cannabis were legalized nationally. In addition to current operations, the Company anticipated acquisition of new operations adding over $2,100,000 to the company's growth plan.

Feb. 14, 2013  - Announced that, based on the submission to OTC Markets of the required Initial Company Information and Disclosure Statement and its Initial Financial Disclosure dated December 31, 2012, together with the stipulated Legal Opinion Letter, it has been upgraded by OTC Markets to the highest trading status of "Current Information". By meeting the OTC Markets Group Guidelines for Providing Current Information guidelines, the Company will now be designated by OTC Pink Current Information. And as further evidence of its commitment to eventually becoming a fully reporting entity, the Company has brought its status with the State of Delaware to the Active current level through the completion of the required State filings and fees; and has filed the required Form 15 with the Securities Exchange Commission.

Feb. 27, 2013 - Based on new Business Plan that calls for acquisitions and growth in the Medical Marijuana Industry. In addition to its current operations and prior acquisitions, the Company has formed new partnerships with various medical marijuana dispensaries and edibles that may transform into strategic and acquisition candidates.  Management scheduled several site visits and meetings with potential joint venture and acquisition candidates moving forward plans and strategies on how they could fit into the new strategic model.

March 20, 2013 - Announced the signing of LOIs to acquire California-based licensing dispensaries and other food-related businesses. In addition to the medical marijuana edibles business, the company is also branching into the high demand/fast growth market of importing fresh seafood from exclusive distributors in Southeast Asia. Plans for the current year call for a forecasted revenue of at least $2,500,000 and $10,000,000 by year end 2015 which we'll be able to achieve by executing a two-prong strategy of both US and international expansion.  The three primary drivers of shareholders value in the growth strategy:

1. Revenue Growth: With 1-2 planned acquisitions in the next 30-60 days, we'll be on our way to achieve our targeted revenue of $2,500,000 by the end of this year.

2. Cash Flow Growth: Maintain profit margins to ensure cash balance is strong in preparation for future partnership and acquisition deals.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,687.51 -58.47 -0.33%
S&P 500 2,110.80 +2.17 0.10%
NASDAQ 5,137.6990 +8.9140 0.17%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs